بدائل البحث:
significant side » significant sex (توسيع البحث), significant burden (توسيع البحث), significant source (توسيع البحث)
point decrease » point increase (توسيع البحث)
side decrease » sizes decrease (توسيع البحث), fid decreased (توسيع البحث), step decrease (توسيع البحث)
significant side » significant sex (توسيع البحث), significant burden (توسيع البحث), significant source (توسيع البحث)
point decrease » point increase (توسيع البحث)
side decrease » sizes decrease (توسيع البحث), fid decreased (توسيع البحث), step decrease (توسيع البحث)
-
41
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
42
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
43
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
44
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
45
-
46
-
47
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
منشور في 2025الموضوعات: -
48
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
49
-
50
-
51
-
52
-
53
-
54
MiR-129-5p levels were decreased in mouse depression models.
منشور في 2025"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …"
-
55
-
56
-
57
-
58
-
59
-
60